Edwards Lifesciences (EW) Asset Utilization Ratio (2010 - 2026)

Edwards Lifesciences has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.48 in Q2 2026.

• On a quarterly basis, Asset Utilization Ratio rose 11.7% year-over-year to 0.48 in Q2 2026; TTM through Jun 2026 was 0.48, a 11.7% increase from a year earlier, with the FY2025 full-year figure at 0.45, down 6.52% from the prior year.
• Asset Utilization Ratio was 0.48 for Q2 2026 at Edwards Lifesciences, up from 0.47 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.64 in Q2 2022, with the low at 0.42 in Q4 2024.
• Average Asset Utilization Ratio over 5 years is 0.5, with a median of 0.48 recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio decreased 27.74% in 2023, then gained 11.7% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.53 in 2022, then grew by 1.43% to 0.53 in 2023, then slipped by 21.85% to 0.42 in 2024, then climbed by 7.65% to 0.45 in 2025, then increased by 6.46% to 0.48 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.48 (Q2 2026), 0.47 (Q1 2026), and 0.45 (Q4 2025), per Business Quant data.